NEULANDLABNSENeuland Laboratories Limited· PharmaceuticalsMediumNeutral
Announced Wed, 23 Jul · 19:20 IST

Addendum to the Notice of 41st Annual General Meeting

Board & Shareholder Meetings View source PDF

NEULANDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Neuland Laboratories has issued an addendum to the notice of its 41st Annual General Meeting (AGM) scheduled for July 30, 2025, at 10:00 AM via video conferencing. The addendum provides additional clarity on the commission (variable pay) payable to Mr. Davuluri Saharsh Rao during his proposed reappointment, which is the subject of Item No. 6 (Special Resolution). The commission is capped at the lower of 2% of net profits or INR 10 crores per financial year, with 60% linked to financial parameters (revenue growth, CMS business growth, contribution) and 40% to non-financial parameters (capability building, customer satisfaction, brand building, new product development, compliance, employee engagement, sustainability). If overall achievement falls below 70%, no commission will be paid. The date, time, and all other AGM agenda items remain unchanged.

Likely market impact

Shareholders now have more transparency on the performance-linked pay structure for the executive being reappointed, with clear caps and measurable KPIs. This adds clarity but is unlikely to materially move the stock, as the AGM date and other resolutions are unchanged.